Home/Filings/4/0001104659-23-112570
4//SEC Filing

Dunn Gordon 4

Accession 0001104659-23-112570

CIK 0001671502other

Filed

Oct 29, 8:00 PM ET

Accepted

Oct 30, 4:12 PM ET

Size

6.0 KB

Accession

0001104659-23-112570

Insider Transaction Report

Form 4
Period: 2023-10-26
Dunn Gordon
Chief Financial Officer
Transactions
  • Award

    Share Option (Right to Buy)

    2023-10-26+51,14951,149 total
    Exercise: $5.75From: 2024-10-26Exp: 2033-10-26American Depositary Share (51,149 underlying)
Footnotes (2)
  • [F1]The number of securities underlying the option and the exercise price are listed in terms of American Depositary Shares ("ADSs"), with sixty thousand (60,000) ordinary shares of the Issuer represented by one (1) ADS.
  • [F2]The option vests in four annual installments with 20% vesting on each of October 26, 2024, 2025 and 2026 and 40% vesting on October 26, 2027.

Issuer

Quoin Pharmaceuticals, Ltd.

CIK 0001671502

Entity typeother

Related Parties

1
  • filerCIK 0001958139

Filing Metadata

Form type
4
Filed
Oct 29, 8:00 PM ET
Accepted
Oct 30, 4:12 PM ET
Size
6.0 KB